维立志博从靶点创新到_老虎社区_美港股上老虎

维立志博从靶点创新到临床开发再到全球化布局都有，在 ADC、IO2.0、TCE 技术平台有优势，感觉更多的是体系化优势

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":446620579172864,"tweetId":"446620579172864","gmtCreate":1750044209698,"gmtModify":1750044454216,"author":{"id":4090740624034750,"idStr":"4090740624034750","authorId":4090740624034750,"authorIdStr":"4090740624034750","name":"创富财经","avatar":"https://static.tigerbbs.com/68929b21556532171a5f482440f61617","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>维立志博从靶点创新到临床开发再到全球化布局都有，在 ADC、IO2.0、TCE 技术平台有优势，感觉更多的是体系化优势</body></html>","htmlText":"<html><head></head><body>维立志博从靶点创新到临床开发再到全球化布局都有，在 ADC、IO2.0、TCE 技术平台有优势，感觉更多的是体系化优势</body></html>","text":"维立志博从靶点创新到临床开发再到全球化布局都有，在 ADC、IO2.0、TCE 技术平台有优势，感觉更多的是体系化优势","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/446620579172864","repostId":0,"isVote":1,"tweetType":1,"viewCount":450,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":99,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}